Professor Derek Manas, the medical director of NHS Blood and Transplant, has sharply criticized the leadership of NHS England and a select group of patient advocates regarding the national organ transplant system. In a letter, Manas asserted that the current structure has resulted in a "fragmented" system characterized by "poor accountability."
Manas highlighted a significant "mismatch" between individual hospital waiting lists, the availability of organs, the capacity to perform surgeries, and the availability of operating theaters. This disjuncture, he warned, is "leading to last-minute cancellations [and] unpredictable utilisation of donated organs."
These issues come as the United Kingdom has seen a decline in its position as a global leader in organ transplantation. While the UK historically excelled in areas such as kidney transplantation, it has fallen behind other major Western nations in heart and lung transplants, according to a March BBC report. The UK transplants approximately one in ten donated lungs and one in seven donated hearts, figures that are half the proportion seen in some other countries.
Contributing factors to this decline include underinvestment in modern transplant technologies compared to international peers, and a persistent shortage of operating theater space, intensive care beds, and specialized staff.
The geographical distribution of transplant services also presents challenges. Patients in Wales and Northern Ireland, which do not have dedicated heart and lung transplant centers, frequently travel to England for surgery. Scotland has a single heart transplant center.
NHS Blood and Transplant is responsible for managing organ donations and providing support to transplant centers. However, the commissioning and funding of these services fall under NHS England. The critiques from Professor Manas point to systemic issues within this management structure that are impacting patient care and the effectiveness of the organ donation program.